4.8 Article

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Related references

Note: Only part of the references are listed.
Article Surgery

Effects of dual antiplatelet therapy on graft patency after lower extremity bypass

Nathan Belkin et al.

Summary: This study found an increasing proportion of patients receiving DAPT after lower extremity bypass surgery, with DAPT showing better patency outcomes in the prosthetic bypass conduit group. However, overall bypass graft patency and major adverse limb events did not differ significantly between the DAPT and aspirin treatment groups. Further research is needed to determine the optimal duration of DAPT therapy and possible bleeding complications in patients with prosthetic bypass conduits.

JOURNAL OF VASCULAR SURGERY (2021)

Article Medicine, General & Internal

Rivaroxaban in Peripheral Artery Disease after Revascularization

Marc P. Bonaca et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Association between complications and death within 30 days after noncardiac surgery

Jessica Spence et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Acute Limb Ischemia in Peripheral Artery Disease Insights From EUCLID

Connie N. Hess et al.

CIRCULATION (2019)

Article Surgery

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Michael S. Conte et al.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2019)

Article Peripheral Vascular Disease

ESVM Guideline on peripheral arterial disease

Ulrich Frank et al.

VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2019)

Editorial Material Surgery

The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures

R. Eugene Zierler et al.

JOURNAL OF VASCULAR SURGERY (2018)

Review Cardiac & Cardiovascular Systems

Peripheral artery disease: epidemiology and global perspectives

F. Gerry R. Fowkes et al.

NATURE REVIEWS CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54

Marc P. Bonaca et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Medicine, General & Internal

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

J. W. Eikelboom et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

Marc P. Bonaca et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial

Matthew T. Menard et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Article Medicine, General & Internal

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Jackson T. Wright et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Lars Ryden et al.

EUROPEAN HEART JOURNAL (2013)

Article Cardiac & Cardiovascular Systems

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

Michal Tendera et al.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)

Review Surgery

Inter-society consensus for the management of peripheral arterial disease (TASC II)

L. Norgren et al.

JOURNAL OF VASCULAR SURGERY (2007)

Article Surgery

Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation

H Pärsson et al.

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2004)